Business Description
Spineway
ISIN : FR001400N2P2
Total Employee Number:
43Compare
Compare
Traded in other countries / regions
ALSPW.France37S.Germany IPO Date
2021-02-15Description
Spineway designs produce and markets implant lines and ancillary surgical equipment used for the treatment of severe disorders of the spinal column. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, and other such medical instruments.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.29 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -1.4 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.88 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 717.9 | |||||
3-Year EBITDA Growth Rate | -382.4 | |||||
3-Year EPS without NRI Growth Rate | 1088.7 | |||||
3-Year FCF Growth Rate | -220.8 | |||||
3-Year Book Growth Rate | -96.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 86.99 | |||||
9-Day RSI | 74.32 | |||||
14-Day RSI | 64.58 | |||||
3-1 Month Momentum % | -14.44 | |||||
6-1 Month Momentum % | -31.91 | |||||
12-1 Month Momentum % | 8.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.88 | |||||
Quick Ratio | 1.8 | |||||
Cash Ratio | 0.79 | |||||
Days Inventory | 510.82 | |||||
Days Sales Outstanding | 88.22 | |||||
Days Payable | 173.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2509.6 | |||||
Shareholder Yield % | 6.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.48 | |||||
Operating Margin % | -12.94 | |||||
Net Margin % | -18.01 | |||||
EBITDA Margin % | -8.75 | |||||
FCF Margin % | -1.31 | |||||
OCF Margin % | -1.31 | |||||
ROE % | -9.43 | |||||
ROA % | -7.45 | |||||
ROIC % | -6.73 | |||||
3-Year ROIIC % | 56.58 | |||||
ROC (Joel Greenblatt) % | -30.15 | |||||
ROCE % | -9.16 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.01 | |||||
PS Ratio | 0.47 | |||||
PB Ratio | 0.25 | |||||
Price-to-Tangible-Book | 0.45 | |||||
EV-to-EBIT | -1.3 | |||||
EV-to-EBITDA | -2.77 | |||||
EV-to-Revenue | 0.24 | |||||
EV-to-FCF | -19.74 | |||||
| Price-to-Net-Current-Asset-Value | 0.96 | |||||
Earnings Yield (Greenblatt) % | -76.86 | |||||
FCF Yield % | -3.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spineway Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 12.43 | ||
| EPS (TTM) (€) | -0.023 | ||
| Beta | 0.8194 | ||
| 3-Year Sharpe Ratio | -1.71 | ||
| 3-Year Sortino Ratio | -1.65 | ||
| Volatility % | 39.04 | ||
| 14-Day RSI | 64.58 | ||
| 14-Day ATR (€) | 0.004632 | ||
| 20-Day SMA (€) | 0.11779 | ||
| 12-1 Month Momentum % | 8.66 | ||
| 52-Week Range (€) | 0.1062 - 0.2625 | ||
| Shares Outstanding (Mil) | 35.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spineway Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spineway Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.0005:1 Stock Split | 2024-02-27 | 1.60 (+14.29%) | ||
| 0.000025:1 Stock Split | 2022-09-15 | 8,000.00 (-50.00%) |
Show
Entries
Spineway Frequently Asked Questions
What is Spineway(FRA:37S)'s stock price today?
The current price of FRA:37S is €0.13. The 52 week high of FRA:37S is €0.26 and 52 week low is €0.11.
When is next earnings date of Spineway(FRA:37S)?
The next earnings date of Spineway(FRA:37S) is .
Does Spineway(FRA:37S) pay dividends? If so, how much?
Spineway(FRA:37S) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Spineway
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers